ストックスクリーナーアプリを入手
180.37
0.04%
0.0054
前日終値:
$180.36
開ける：
$180.54
24時間の取引高:
88,022
Relative Volume:
0.09
時価総額：
$20.17B
収益：
$9.54B
当期純損益:
$841.00M
株価収益率:
24.24
EPS:
7.44
ネットキャッシュフロー:
$1.02B
1週間 パフォーマンス:
-2.15%
1か月 パフォーマンス:
+7.05%
6か月 パフォーマンス:
+5.18%
1年 パフォーマンス:
+17.47%
1日の値動き範囲:
$179.55
$180.89
1週間の範囲:
$176.97
$185.62
52週間の値動き範囲:
$146.17
$185.62
Quest Diagnostics Inc Stock (DGX) Company Profile
DGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
180.38 | 19.98B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
483.68 | 185.31B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
204.54 | 148.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
642.04 | 51.31B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.29 | 33.85B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
186.38 | 31.96B | 15.70B | 1.24B | 2.01B | 6.91 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-02 | 開始されました | Redburn Atlantic | Buy |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-01-06 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | Jefferies | Buy |
| 2024-10-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 再開されました | Evercore ISI | In-line |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-12-12 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-06-29 | 開始されました | Piper Sandler | Neutral |
| 2023-05-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-01-23 | 開始されました | Evercore ISI | In-line |
| 2022-11-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-04-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-02-23 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-02 | ダウングレード | Jefferies | Buy → Hold |
| 2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-04 | アップグレード | UBS | Neutral → Buy |
| 2021-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | アップグレード | Argus | Hold → Buy |
| 2020-07-29 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-06-09 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-04-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
| 2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-12-19 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | ダウングレード | Goldman | Neutral → Sell |
| 2019-04-02 | アップグレード | Jefferies | Hold → Buy |
| 2019-03-18 | 再開されました | Credit Suisse | Neutral |
| 2019-01-31 | ダウングレード | Argus | Buy → Hold |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Quest Diagnostics Inc (DGX) 最新ニュース
What data driven models say about Quest Diagnostics Incorporated’s futureEarnings Growth Report & Low Drawdown Investment Ideas - Newser
Custom strategy builders for tracking Quest Diagnostics IncorporatedOptions Play & High Accuracy Trade Signal Alerts - Newser
Historical volatility pattern of Quest Diagnostics Incorporated visualized2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
Relative strength of Quest Diagnostics Incorporated in sector analysisJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
Can trapped investors hope for a rebound in Quest Diagnostics IncorporatedJuly 2025 Big Picture & Stepwise Entry and Exit Trade Signals - Newser
Market reaction to Quest Diagnostics Incorporated’s recent news2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Earnings visualization tools for Quest Diagnostics IncorporatedPortfolio Update Report & Weekly Hot Stock Watchlists - Newser
Identifying reversal signals in Quest Diagnostics IncorporatedWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
What’s the recovery path for long term holders of Quest Diagnostics IncorporatedJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
What MACD and RSI say about Quest Diagnostics IncorporatedBear Alert & Daily Entry Point Trade Alerts - Newser
Quest Diagnostics, Corewell Health agree to joint venture - Modern Healthcare
Using AI based signals to follow Quest Diagnostics IncorporatedJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Statistical indicators supporting Quest Diagnostics Incorporated’s strengthWeekly Stock Report & Daily Volume Surge Trade Alerts - Newser
Will earnings trigger a reversal in Quest Diagnostics IncorporatedPortfolio Value Summary & Weekly Stock Breakout Alerts - Newser
Quest Diagnostics, Corewell Health Enter Joint Venture for Laboratory Services in Michigan - MarketScreener
Corewell Health, Quest Diagnostics form lab services joint venture By Investing.com - Investing.com Canada
Stepping Stones Inc., to Provide Special Screening of Award-Winning Documentary – GENERATION GROWTH – courtesy of Quest Diagnostics | Newswise - Newswise
Corewell Health and Quest Diagnostics to enter into joint venture providing enhanced laboratory services in Michigan - MarketScreener
FDA grants breakthrough device designation for Quest Diagnostics’ MRD test - Medical Device Network
Are Wall Street Analysts Predicting Quest Diagnostics Stock Will Climb Or Sink? - Barchart.com
100,000 Sq Ft Super Lab: Quest Diagnostics & Corewell Health Form Massive Michigan Joint Venture - Stock Titan
Quest Diagnostics Incorporated stock trendline breakdownJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Can you recover from losses in Quest Diagnostics IncorporatedChart Signals & Stepwise Swing Trade Plans - Newser
Resistance Break Could Fuel Quest Diagnostics Incorporated Rally2025 Bull vs Bear & Growth Focused Stock Pick Reports - beatles.ru
This Quest Diagnostics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Quest Diagnostics: Baird downgrades to 'Neutral' Rating, The Target Price is $194 - AInvest
Quest receives FDA Breakthrough Device designation for colorectal cancer test - Seeking Alpha
Quest Diagnostics Says Haystack MRD Test Granted US FDA Breakthrough Device Designation - MarketScreener
FDA Fast-Tracks Revolutionary Blood Test: Quest Diagnostics' Breakthrough Could Transform Colorectal Cancer Care - Stock Titan
Baird Downgrades Quest Diagnostics to Neutral From Outperform, Price Target is $194 - MarketScreener
What momentum shifts mean for Quest Diagnostics Incorporated2025 Winners & Losers & Low Risk Entry Point Guides - Newser
Quest Diagnostics Incorporated recovery potential after sell offTreasury Yields & Safe Swing Trade Setup Alerts - Newser
Is Quest Diagnostics Incorporated stock bottoming outPortfolio Gains Summary & Daily Growth Stock Investment Tips - Newser
Is Quest Diagnostics Incorporated a strong candidate for buy and holdPortfolio Return Report & Real-Time Volume Trigger Notifications - theviewers.co.kr
Quest Diagnostics Stock Drops 1.94% After Reaching 25-Year High - AInvest
Insider Selling at Quest Diagnostics: Signal or Noise in a Seasoned Market? - AInvest
Should Quest Diagnostics Stock Be in Your Portfolio Right Now? - Zacks Investment Research
Decoding Insider Sales at Quest Diagnostics: Is This a Sign of Overvaluation or Prudent Diversification? - AInvest
Plewman, Quest Diagnostics SVP, sells $355k in stock - Investing.com
Quest Diagnostics Incorporated Stock Performance After Earnings: Historical InsightsMarket Performance Recap & Safe Entry Momentum Tips - Newser
Quest Diagnostics Introduces Testing for Oropouche Virus - Eastern Progress
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference - Eastern Progress
Can a trend reversal in Quest Diagnostics Incorporated lead to recoveryTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - Newser
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare C - GuruFocus
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference – Company Announcement - Financial Times
Leading Diagnostics Provider Quest Diagnostics CEO to Share Market Insights at Baird Healthcare Conference - Stock Titan
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock - Yahoo Finance
Quest Diagnostics Declares Quarterly Cash Dividend, Payable on October 20, 2025 - MarketScreener
Quest Diagnostics Declares Quarterly Cash Dividend of $0.80 per Share - AInvest
Quest Diagnostics Declares Quarterly Cash Dividend – Company Announcement - Financial Times
Medical Testing Giant Quest Diagnostics Maintains $0.80 Quarterly Dividend Payout - Stock Titan
Quest Diagnostics Inc (DGX) 財務データ
収益
当期純利益
現金流量
EPS
Quest Diagnostics Inc (DGX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Plewman Patrick | SVP for Diagnostic Services |
Aug 19 '25 |
Option Exercise |
112.17 |
4,532 |
508,354 |
21,776 |
| Plewman Patrick | SVP for Diagnostic Services |
Aug 19 '25 |
Sale |
183.00 |
4,532 |
829,356 |
17,244 |
0.86%
大文字化:
|
ボリューム (24 時間):